Satani S. and Ratna Trivedi. An Emergence of Multidrug Resistant Nosocomial Pathogen -
.
. 2022; 10(1):1-8. doi: 10.12691/AJMBR-10-1-1
MDR, mechanism of resistance, nosocomial infection, risk factor
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Alsan, M. & Klompas, M. Acinetobacter baumannii: An Emerging and Important Pathogen. Journal of Clinical Outcomes and Managment. 17, 363-369 (2010). |
|
[2] | Bonomo, R. A. Pathogenesis of Acinetobacter spp (Case Western Reserve University, 2010). |
|
[3] | Baumann, P., Doudoroff, M. & Stanier, R. Y. A Study of the Moraxellk Group II. Oxidative-negative Species (Genus Acinetobacter). Journal of bacteriology 95, 1520-1541 (1968). |
|
[4] | Fournier, P. E. et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS genetics 2, e7, (2006). |
|
[5] | Du, X. et al. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis. American journal of infection control 47, 1140-1145, (2019). |
|
[6] | Yang, C. H., Su, P. W., Moi, S. H. & Chuang, L. Y. Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation. Molecules 24, (2019). |
|
[7] | Trottier, V. et al. Outcomes of Acinetobacter baumannii infection in critically ill burned patients. Journal of burn care & research: official publication of the American Burn Association 28, 248-254, (2007). |
|
[8] | Howard, A., O'Donoghue, M., Feeney, A. & Sleator, R. D. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 3, 243-250, (2012). |
|
[9] | Gaynes, R. & Edwards, J. R. Overview of Nosocomial Infections Caused by Gram-Negative Bacilli. Healthcare Epidemiology 41, 848-854 (2005). |
|
[10] | Doughari, H. J., Ndakidemi, P. A., Human, I. S. & Benade, S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes and environments 26, 101-112, (2011). |
|
[11] | Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clinical microbiology reviews 21, 538-582, (2008). |
|
[12] | Garnacho-Montero, J. et al. Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia. Expert review of anti-infective therapy 13, 769-777, (2015). |
|
[13] | Wood, G. C., Hanes, S. D., Boucher, B. A., Croce, M. A. & Fabian, T. C. Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Intensive care medicine 29, 2072-2076, doi:10.1007/s00134-003-1811-2 (2003). |
|
[14] | Basri, R. et al. Burden of Bacterial Meningitis: A Retrospective Review on Laboratory Parameters and Factors Associated With Death in Meningitis, Kelantan Malaysia. Nagoya J. Med. Sci. 77. 59-68, 2015 77, 59-68 (2015). |
|
[15] | Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R. & Murray, C. K. Infectious complications of open type III tibial fractures among combat casualties. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 45, 409-415, (2007). |
|
[16] | Murray, C. K. et al. Bacteriology of war wounds at the time of injury. Military medicine 171, 826-829, (2006). |
|
[17] | Bergogne-Be´re´zin, E. & Towner, K. J. Acinetobacter spp. as Nosocomial Pathogens: Microbiological, Clinical, and Epidemiological Features. Clinical Microbiology Reviews, Apr. 1996, p. 148-165 9, 148-165 (1996). |
|
[18] | Antunes, L. C., Visca, P. & Towner, K. J. Acinetobacter baumannii: evolution of a global pathogen. Pathogens and disease 71, 292-301, (2014). |
|
[19] | Choi, C. H. et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cellular microbiology 7, 1127-1138, (2005). |
|
[20] | Gaddy, J. A. et al. Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun 80, 1015-1024, (2012). |
|
[21] | Gaddy, J. A., Tomaras, A. P. & Actis, L. A. The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells. Infection and Immunity 77, 3150-3160, (2009). |
|
[22] | Rumbo, C. et al. The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. Infect Immun 82, 4666-4680, (2014). |
|
[23] | Smani, Y., Dominguez-Herrera, J. & Pachon, J. Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. The Journal of infectious diseases 208, 1561-1570, doi:10.1093/infdis/jit386 (2013). |
|
[24] | Smani, Y., McConnell, M. J. & Pacho´n, J. Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells. PloS one 7, e33073, (2012). |
|
[25] | Smani, Y. & Pachon, J. Loss of the OprD homologue protein in Acinetobacter baumannii: impact on carbapenem susceptibility. Antimicrobial agents and chemotherapy 57, 677, (2013). |
|
[26] | Kenyon, J. J. & Hall, R. M. Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes. PloS one 8, e62160, (2013). |
|
[27] | Geisinger, E. & Isberg, R. R. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS pathogens 11, e1004691, (2015). |
|
[28] | Liou, M. L. et al. The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 47, 275-281, (2014). |
|
[29] | Luke, N. R. et al. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect Immun 78, 2017-2023, (2010). |
|
[30] | Stahl, J., Bergmann, H., Gottig, S., Ebersberger, I. & Averhoff, B. Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D. PloS one 10, e0138360, (2015). |
|
[31] | Kwon, S. O., Gho, Y. S., Lee, J. C. & Kim, S. I. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS microbiology letters 297, 150-156, (2009). |
|
[32] | Jin, J. S. et al. Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles. PloS one 6, e17022, (2011). |
|
[33] | Huang, W. et al. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PloS one 9, e100727, (2014). |
|
[34] | Korotkov, K. V., Sandkvist, M. & Hol, W. G. The type II secretion system: biogenesis, molecular architecture and mechanism. Nature reviews. Microbiology 10, 336-351, (2012). |
|
[35] | Repizo, G. D. et al. Differential Role of the T6SS in Acinetobacter baumannii Virulence. PloS one 10, e0138265, (2015). |
|
[36] | Bentancor, L. V., Camacho-Peiro, A., Bozkurt-Guzel, C., Pier, G. B. & Maira-Litran, T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. Journal of bacteriology 194, 3950-3960, (2012). |
|
[37] | Koenigs, A., Zipfel, P. F. & Kraiczy, P. Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein. PloS one 10, e0138398, (2015). |
|
[38] | Liu, C. et al. Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates. Oncotarget 9, 21663-21673 (2018). |
|
[39] | Ardebili, A., Lari, A. R., Beheshti, M. & Lari, E. R. Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance. Iranian Journal of Basic Medical Sciences 18, 623-626 (2015). |
|
[40] | Drlica, K. & Zhao, X. DNA Gyrase, Topoisomerase IV, and the 4-Quinolones. Microbiology and Molecular Biology Reviews 61, 377-392 (1997). |
|
[41] | Mak, J. K., Kim, M. J., Pham, J., Tapsall, J. & White, P. A. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. The Journal of antimicrobial chemotherapy 63, 47-54, (2009). |
|
[42] | Hujer, K. M. et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrobial agents and chemotherapy 50, 4114-4123, (2006). |
|
[43] | Koh, T. H., Sng, L. H., Wang, G. C., Hsu, L. Y. & Zhao, Y. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. The Journal of antimicrobial chemotherapy 59, 627-632, (2007). |
|
[44] | Landman, D. et al. Citywide Clonal Outbreak of Multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY. ARCH INTERN MED 162, 1515-1520 (2002). |
|
[45] | Docquier, J. D. et al. On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. The Journal of antimicrobial chemotherapy 51, 257-266, (2003). |
|
[46] | Nagano, N., Nagano, Y., Cordevant, C., Shibata, N. & Arakawa, Y. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. Journal of clinical microbiology 42, 3978-3984, (2004). |
|
[47] | Potron, A., Munoz-Price, L. S., Nordmann, P., Cleary, T. & Poirel, L. Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. Antimicrobial agents and chemotherapy 55, 5946-5948, (2011). |
|
[48] | LS, T. & RA, B. SHV-type beta-lactamases. Current Pharmaceutical Design 5, 847-864 (1999). |
|
[49] | Naas, T. et al. VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France. Emerging Infectious Diseases 12, 1214-1222, (2006). |
|
[50] | Jeon, B. C. et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. Journal of clinical microbiology 43, 2241-2245, (2005). |
|
[51] | Pasteran, F. et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas. Antimicrobial agents and chemotherapy 50, 3222-3224, (2006). |
|
[52] | Shaw, K. J., Rather, P. N., Hare, R. S. & Miller, G. H. Molecular Genetics of Aminoglycoside Resistance Genes and Familial Relationships of the Aminoglycoside-Modifying Enzymes. Microbiological Reviews 57, 138-163 (1993). |
|
[53] | Nemec, A., Dolzani, L., Brisse, S., van den Broek, P. & Dijkshoorn, L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. Journal of medical microbiology 53, 1233-1240, (2004). |
|
[54] | Jones, L. A., McIver, C. J., Kim, M. J., Rawlinson, W. D. & White, P. A. The aadB gene cassette is associated with blaSHV genes in Klebsiella species producing extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy 49, 794-797, (2005). |
|
[55] | N.Rather, P. Origins of the aminoglycoside modifying enzymes. Drug Resistance Updates 1, 285-291 (1998). |
|
[56] | Marchand, I., Damier-Piolle, L., Courvalin, P. & Lambert, T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrobial agents and chemotherapy 48, 3298-3304, (2004). |
|
[57] | Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P. & Perichon, B. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrobial agents and chemotherapy 54, 4389-4393, (2010). |
|
[58] | Vilacoba, E. et al. Emergence and Spread of Plasmid-Borne tet(B)::ISCR2 in Minocycline-Resistant Acinetobacter baumannii Isolates. Antimicrobial agents and chemotherapy 57, 651-654 (2013). |
|
[59] | Coyne, S., Courvalin, P. & Perichon, B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrobial agents and chemotherapy 55, 947-953, (2011). |
|
[60] | Roca, I. et al. CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrobial agents and chemotherapy 53, 4013-4014, (2009). |
|
[61] | Rajamohan, G., Srinivasan, V. B. & Gebreyes, W. A. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. The Journal of antimicrobial chemotherapy 65, 1919-1925, (2010). |
|
[62] | Sharma, A., Sharma, R., Bhattacharyya, T., Bhando, T. & Pathania, R. Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF. The Journal of antimicrobial chemotherapy 72, 68-74, (2017). |
|
[63] | Su, X. Z., Chen, J., Mizushima, T., Kuroda, T. & Tsuchiya, T. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrobial agents and chemotherapy 49, 4362-4364, (2005). |
|
[64] | Barnard, F. M. & Maxwell, A. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87). Antimicrobial agents and chemotherapy 45, 1994-2000, (2001). |
|
[65] | Yu, Y. S., Zhou, H., Yang, Q., Chen, Y. G. & Li, L. J. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. The Journal of antimicrobial chemotherapy 60, 454-455, doi:10.1093/jac/dkm208 (2007). |
|
[66] | Cayo, R. et al. Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii. Antimicrobial agents and chemotherapy 55, 5907-5913, (2011). |
|
[67] | Ribera, A., Ruiz, J. & Vila, J. Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii. Antimicrobial agents and chemotherapy 47, 2310-2312, (2003). |
|
[68] | Adams, M. D. et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrobial agents and chemotherapy 53, 3628-3634, (2009). |
|
[69] | Moffatt, J. H. et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrobial agents and chemotherapy 54, 4971-4977, (2010). |
|
[70] | Arroyo, L. A. et al. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrobial agents and chemotherapy 55, 3743-3751, (2011). |
|
[71] | Mussi, M. A., Relling, V. M., Limansky, A. S. & Viale, A. M. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS letters 581, 5573-5578, (2007). |
|
[72] | Bou, G. n., M., G. C., Dom, A. & Carmen Quereda. Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance in A. baumannii Is Not Due Solely to the Presence of β-Lactamases. Journal of clinical microbiology 38, 3299-3505 (2000). |
|
[73] | del Mar Tomas, M. et al. Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii. Antimicrobial agents and chemotherapy 49, 5172-5175, (2005). |
|
[74] | Quale, J., Bratu, S., Landman, D. & Heddurshetti, R. Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii Endemic in New York City. Clinical Infectious Diseases 37, 214-220 (2003). |
|
[75] | Dupont, M., Pagès, J.-M., Lafitte, D., Siroy, A. & Bollet, C. Identification of an OprD homologue in Acinetobacter baumannii. Journal of Proteome Research 4, 2386-2390 (2005). |
|
[76] | Vijayakumar, S., Biswas, I. & Veeraraghavan, B. Accurate identification of clinically important Acinetobacter spp.: an update. Future Science OA 5, 1-18 (2019). |
|
[77] | Khan, M. F. & Aziz, F. Antibiotic Resistance: Preparation for Post-Antibiotic Era. EC Microbiology 3, 409-411 (2016). |
|
[78] | Urban, C. et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. 167, 448-452 (1993). |
|
[79] | Corbella, X. et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. Journal of Antimicrobiology and Chemotherapy 42, 793-802 (1998). |
|
[80] | Dinc, G. et al. Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii. New Microbiologica 38, 67-73 (2015). |
|
[81] | Paudel, R. & Nepal, H. P. Tigecycline: pharmacological concerns and resistance. International Journal of Basic & Clinical Pharmacology 9, 1296, (2020). |
|
[82] | Cunha, B. A., Mcdermott, B. & Nausheen, S. Single Daily High-Dose Tigecycline Therapy of a Multidrug-Resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes Nosocomial Urinary Tract Infection. Journal of Chemotherapy 19, 753-754 (2007). |
|
[83] | Navon-Venezia, S., Leavitt, A. & Carmeli, Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. Journal of Antimicrobiology and Chemotherapy 59, 772-724 (2007). |
|
[84] | Al-Agamy, M. H. et al. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Microbial Drug Resistance 23, 556-562 (2017). |
|
[85] | Tsioutis, C. et al. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients. International Journal of Antimicrobial Agents 48, 492-497 (2016). |
|
[86] | Koksal, I., Kaya, S., Gencalioglu, E. & Yilmaz, G. Evaluation of Risk Factors for Intravenous Colistin Use-related Nephrotoxicity. Oman Medical Journal 31, 318-321, (2016). |
|
[87] | Ozkan, G. et al. How does colistin-induced nephropathy develop and can it be treated? Antimicrobial agents and chemotherapy 57, 3463-3469 (2013). |
|
[88] | Hejnar, P., Kolár, M. & Hájek, V. Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc. Acta University Palacki Olomuc Faculty of Medicine 142, 73-77 (1999). |
|
[89] | Baadani, A. M., Thawadi, S. I., El-Khizzi, N. A. & Omrani, A. S. Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period. Suadi Medicine Journal 34, 248-253 (2013). |
|
[90] | Maspi, H., Hosseini, H. M., Amin, M. & Fooladi, A. A. I. High prevalence of extensively drug-resistant and metallo beta-lactamase-producing clinical Acinetobacter baumannii in Iran. Microbiology and Pathology 98, 155-159 (2016). |
|
[91] | Gupta, M. et al. Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat. Journal of Hospital Infection 94, 72-73 (2016). |
|